Výsledky vyhledávání - "R N Janet Gammon"

Phase I study of fotemustine in pediatric patients with refractory brain tumors

Autor: Ron M. Grant, Nauman Tariq, Darren R. Hargrave, Sylvain Baruchel, Eric Bouffet, R N Janet Gammon

Publikováno v: Cancer. 95:1294-1301

BACKGROUND Fotemustine is a nitrosourea with theoretic and preclinical advantages over the original analogs, carmustine and lomustine, in the treatment of brain tumors. This is the first pediatric Phase I study of fotemustine. METHODS Patients younge

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb8943a4bd9afffd798fa990b0e8dc02
https://doi.org/10.1002/cncr.10814

Zobrazit plný text záznamu

Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma

Autor: Maryam Fouladi, R N Janet Gammon, Sylvain Baruchel, Mark L. Greenberg, Julia Klein, Diana Stempak, Ron M. Grant, Gideon Koren

Publikováno v: Cancer. 92(4)

BACKGROUND Amifostine protects normal tissues against chemotherapy and radiation-induced toxicity without loss of antitumor effects. Evidence suggests that multiple daily doses of amifostine may improve its cytoprotective effects. The purpose of this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a98c0055e0bcb3eea02001bedde9557
https://pubmed.ncbi.nlm.nih.gov/11550166

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání